Patients’ clinical characteristics ALL(n=12) AML(n=15) APL(n=1)
Sex: Male/Female 7:5 2:1 0:1
Age: 7(3.3-14.8) 11(0.6-15.4) 8
Chromosomal karyotype
Normal karyotype 10(83.3%) 13(86.6%) 1(100%)
Hyperdiploid 2(16.7%) 0 0
-7 0 1(6.7%) 0
t(7; 11)(p15; p15) 0 1(6.7%) 0
Level of risk
Low risk 1(8.3%) 3(20.0%) 1(100%)
Intermediate risk 9(75.0%) 2(13.3%) 0
High risk 2(16.7%) 10(66.7%) 0
Treatment protocols
Targeted drugs 3(25.0%) 7(46.7%) 0
Transplantation 0 9(60.0%) 0